Document Type

Patent

Publication Date

April 2014

Patent Number

8697095

Abstract

A method of treating gamma oncogenic herpesviruses, in vivo, through use of Delta-9 Tetrahydrocannabinol (THC). THC inhibits KSHV and EBV reactivation as well as inhibiting lytic replication of MHV 68 and HVS in vitro. Specifically, THC inhibits immediate early gene ORF 50 promoter activity.

Application Number

11/162,582

Assignees

University of South Florida

Filing Date

09/15/2005

Primary/U.S. Class

424/400

Share

COinS